D1ASP0RA was founded in 2016 to launch disruptive healthcare ventures. Areas of primary interest include precision medicine, regenerative medicine, and phenotypic discovery. Precision medicine tailors treatments to each patient. Advanced medicine repairs tissues damaged by disease. Phenotypic discovery identifies more effective drugs. These three areas are key to future healthcare innovation. They operate on common platform technologies including clinical genomics and manufactured cells.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 302 Samuel Dr,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- d1asp0ra.com
- Keywords
- Miami.
- HQ
- Madison, WI
D1asp0ra Questions
D1Asp0Ra's website is d1asp0ra.com
D1Asp0Ra's LinkedIn profile is https://www.linkedin.com/company/d1asp0ra-llc
D1Asp0Ra has
1 employees.
View email and phone details for 1
employees at D1Asp0Ra.
D1Asp0Ra's industry is
Biotechnology Research
D1Asp0Ra's top competitors are
Papillon Therapeutics,
Lyfeline App,
Liberty Rose Studios,
Healthquist Inc.,
Pivotal Logistics,
Rprd Diagnostics,
Vascugen,
Kiji Therapeutics,
Virtual Advisor,
Rxdna.
D1Asp0Ra's categories are Biotechnology Research
D1Asp0Ra's founding year is 2006
